Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes

BACKGROUND: A new special reimbursement scheme (SRS) for non-insulin medications used for treatment of hyperglycaemia in type 2 diabetes (T2D) was implemented in Finland on January 1, 2017. The new SRS affected all community-dwelling Finnish T2D patients as all community-dwelling residents are eligi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Health Serv Res
Autori principali: Lavikainen, Piia, Aarnio, Emma, Jalkanen, Kari, Tirkkonen, Hilkka, Rautiainen, Päivi, Laatikainen, Tiina, Martikainen, Janne
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2020
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694920/
https://ncbi.nlm.nih.gov/pubmed/33246453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-020-05952-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi